Starting dose of blood pressure medication for shock
Part of Heart & circulation clinical trials.
This study compares two starting doses of a medicine called norepinephrine (which helps raise blood pressure) for patients in shock. It aims to find the best dose to quickly stabilize blood pressure and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have shock, meaning your blood pressure is too low (below 65 mmHg).
- You are being treated in the emergency department or the medical intensive care unit.
- Your doctor plans to use norepinephrine as the first medicine to raise your blood pressure.
- You have not received any blood pressure-raising medicines before coming to the hospital.
- You are not pregnant, not a prisoner, and not recovering from a cardiac arrest.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
This Phase 3 study tests whether starting a blood-pressure medicine earlier in the emergency room can improve outcomes for people with low blood pressure or shock. It focuses on patients who have already received enough IV fluids and meet specific blood pressure and lab findings.
This trial studies whether aiming for a higher average blood pressure (using medicines) can better protect kidney function in critically ill adults with shock. You may be asked to have close kidney and heart monitoring while receiving blood-pressure support.
This study tests whether giving low-dose blood pressure medicines through a standard IV (instead of a larger central line) is safe and effective for patients with shock in the intensive care unit.
This trial tests whether using a blood test called renin to guide treatment can help stabilize blood pressure in ICU patients with shock. It may help doctors choose the right medications and targets to reduce complications.
This study compares individualized blood pressure goals versus the usual (standard) targets for adults in the ICU with shock. The aim is to see whether tailored blood pressure treatment can improve outcomes by better matching each person’s needs.
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.